On September 10, 2021, the Administration announced that the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), is making $25.5 billion in new funding available for health care providers affected by the COVID-19 pandemic.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
The American Society of Clinical Oncology (ASCO) recently published “Telehealth in Oncology: ASCO Standards and Practice Recommendations” in JCO Oncology Practice. The document provides oncology-specific standards for using telehealth to treat individuals with cancer.
With COVID-19 case counts rising amid the spread of the Delta variant, the Association for Clinical Oncology joined more than 50 health care professional societies and organizations that represent millions of workers throughout health and long-term care in calling for all health care employers to require their employees to be vaccinated against COVID-19.
In a joint position statement, ASCO and Friends of Cancer Research say individuals with cancer or a history of cancer should be eligible for clinical trials—including COVID-19 vaccine trials—unless there is safety justification for exclusion.
The U.S. Department of Health and Human Services (HHS) released revised reporting requirements for recipients of Provider Relief Fund (PRF) payments. Updates include expanding the amount of time providers will have to report information, efforts to reduce burdens on smaller providers, and extending key deadlines for expending PRF payments for recipients who received payments after June 30, 2020.
The COVID-19 pandemic has profoundly interrupted delivery of key preventive services, resulting in many adolescents missing routine human papillomavirus (HPV) vaccine doses. In response, the American Society of Clinical Oncology (ASCO) and nearly 80 National Cancer Institute (NCI)-designated cancer centers and other organizations issued a joint statement urging the nation’s health care systems, physicians, parents and children, and young adults to get HPV vaccination back on track.
The American Society of Clinical Oncology (ASCO) issued a new position statement outlining the issues that telemedicine cross-state licensure presents for the cancer care community, in addition to ASCO’s recommendations to continue the practice during the COVID-19 pandemic and beyond.
From April 12-16, U.S. members of the Association for Clinical Oncology (ASCO) participated in the 2021 ASCO Advocacy Summit, where 148 advocates from 44 states and the District of Columbia held 222 virtual meetings – the most ever held during an Advocacy Summit – with Members of Congress and staff to urge action on important policies to improve access to high-quality, equitable care for people with cancer.
On Thursday, March 11, President Biden signed a $1.9 trillion COVID-19 relief package into law. The legislation, known as the American Rescue Plan, allocates money for vaccines, schools, small businesses and anti-poverty programs such as an expanded child tax credit that would mean new monthly payments to many parents.
The latest issue of JCO Oncology Practice features a new Special Series of articles examining the disparities and barriers faced in cancer care. The articles detail challenges experienced by people of different cultures, backgrounds, ages, and socioeconomic factors, and provides a framework for addressing disparities in underserved communities.
The Association for Clinical Oncology, as part of the Cancer Leadership Council, sent a letter to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) offering the group’s perspective on progress to date in the effort to vaccinate people with cancer and other serious health concerns against COVID-19.
The Centers for Medicare & Medicaid Services (CMS) announced it will hold physicians harmless from Merit-based Incentive Payment System (MIPS) penalties due to the significant disruptions the COVID-19 public health emergency placed on physician practices’ performance in 2020.
President Biden signed an Executive Order calling for a 100-day review of the United States’ (U.S.) pharmaceutical supply chains in an effort to create more resilient and secure access to essential pharmaceuticals while reducing over reliance on foreign competitors.
The American Society of Clinical Oncology’s (ASCO) Road to Recovery Report: Learning from the COVID-19 Experience to Improve Clinical Research and Cancer Care, among other recommendations, calls for the U.S. Department of Health and Human Services (HHS) to establish a special enrollment period on the federal health insurance exchange, abandon plans that limit access to healthcare, and enact policies that enhance access to care for patients with cancer. ASCO applauds the Biden administration for its recent actions supporting policies that aim to promote and protect access to high-quality, equitable cancer care, as outlined in the “Road to Recovery” report.
In the midst of growing concerns that patients with cancer have limited access to the COVID-19 vaccines, the Association for Clinical Oncology (ASCO) and American Cancer Society Cancer Action Network (ACS CAN), advocacy affiliate of the American Cancer Society, today issued a joint letter to every state governor in the United States urging them to prioritize patients with cancer in the distribution of COVID-19 vaccines in accordance with U.S. Centers for Disease Control and Prevention (CDC) guidelines.